NuCana (NCNA) Expected to Announce Earnings on Wednesday

NuCana (NASDAQ:NCNA) is projected to release its earnings data before the market opens on Wednesday, March 19th. Analysts expect NuCana to post earnings of ($2.43) per share for the quarter.

NuCana Stock Up 9.1 %

NCNA stock opened at $0.83 on Tuesday. The firm has a market cap of $2.19 million, a price-to-earnings ratio of -0.08 and a beta of 0.89. NuCana has a twelve month low of $0.75 and a twelve month high of $10.79. The business’s fifty day simple moving average is $0.99 and its two-hundred day simple moving average is $1.59.

NuCana Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company, through its technology, is developing ProTides medicines to overcome the limitations of nucleoside analogs and generate much higher concentrations of anti-cancer metabolites in cancer cells.